A team of Scientists in Cairns (Australia) and Cardiff (Wales) have developed the world’s first synthetic, thermostable, the non-biologic vaccine that can be taken orally.The team showed that the synthetic vaccine was hyper-stable in both stomach acid and human blood, meaning it could be taken orally.This will be a revolutionary step towards creating new vaccine treatments in pill form.The most interesting aspect of this vaccine is that it does not require refrigeration , thereby obviating process of cold chain required for storage and transport of many current vaccines.This will not only be a matter of convenience but will also cut expenditure incurred for safe delivery of most of the present day vaccines.The findings of the study conducted by the team led by Associate Professor John Miles from James Cook University and Cardiff University’s Professor Andrew Sewell has been published in the Journal of Clinical Investigation.
The new fully synthetic flu vaccine protected mice from potentially lethal doses of swine flu and also worked on human cells when tested in the laboratory.According to investigators this prototype synthetic vaccine would not require refrigeration and could have the long shelf life of few years.
Dr. Kamal Kant Kohli
Latest posts by Dr. Kamal Kant Kohli (see all)
- Lithotripsy improves erectile function in impotence - November 18, 2018
- Rifamycin approved for travellers’ diarrhoea by FDA - November 17, 2018
- PGI study refutes ACP guidelines ,recommends strict HbA1C adherence - November 16, 2018